BioPharma

22 June, 2026 | Monday | Analysis

After the Drug Substance, the Real Squeeze: APAC's Aseptic Fill-Finish Gap

For most of the last decade, the anxiety in Asia-Pacific biomanufacturing pointed upstream. The conversation was about bioreactor volume — how many thousands of litres a campus could install, how fast a C...

Lab

26 June, 2026 | Friday | News

Waters and IMU Biosciences Partner to Advance AI-Powered High-Definition Immune Profiling

MU's AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a single blood sample, analyzed in real time. Waters Biosciences' technologi...

BioTech

26 June, 2026 | Friday | News

Merck Expands Life Science Leadership with Planned $11.3 Billion Bio-Techne Acquisition

Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion) Proposed acquisition expected to be immediately accretive to sales growth and EBITDA pre margin p...

Contract Services

01 July, 2026 | Wednesday | News

Icosagen Completes €45 Million Expansion to Deliver End-to-End Biologics Development and GMP Manufacturing at a Single Site

Estonia-based biotechnology company Icosagen has completed a major strategic expansion to strengthen its integrated biologics development and manufacturing capabilities at a single site, creating a se...

Consumer Health

10 June, 2026 | Wednesday | News

AI Must Shift Healthcare From Crisis Response To Early Intervention Across APAC

As healthcare systems across Asia Pacific confront mounting workforce shortages, ageing populations, and rising chronic disease burdens, artificial intelligence is emerging as a critical enabler of more efficie...

Medtech

01 July, 2026 | Wednesday | News

Terumo Completes First U.S. Procedure with OPUSWAVE Dual-Sensor Imaging System, Advancing Coronary Imaging

Terumo Interventional Systems (TIS), a division of Terumo Corporation, recently completed the first procedure using its OPUSWAVE® Dual Sensor Imaging System. The procedure, performed on June  15 by Ann...

Cell & Gene

01 July, 2026 | Wednesday | News

Ever Supreme Advances Off-the-Shelf CAR-T Therapy CAR001 to Phase IIa After Positive Phase I Safety Review

Ever Supreme Bio Technology Co., Ltd. (TWSE: 6712) announced on June 28 that CAR001, its proprietarily developed, allogeneic, "off-the-shelf" CAR-T cell therapy for cancer, has successfully cleared re...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close